|The STOML2 stoml2 (Catalog #MBS9201476) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The STOML2 Antibody (Center) reacts with Human (Predicted Reactivity: Bovine, Mouse, Rat) and may cross-react with other species as described in the data sheet. MyBioSource\'s STOML2 can be used in a range of immunoassay formats including, but not limited to, Western Blot (WB), ELISA (EIA).
WB~~1:1000. Researchers should empirically determine the suitability of the STOML2 stoml2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The STOML2 stoml2 product has the following accession number(s) (GI #7305503) (NCBI Accession #NP_038470.1) (Uniprot Accession #Q9UJZ1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the STOML2 Antibody (Center) with the following immunoassay(s):
Western Blot (WB) (STOML2 Antibody (Center) western blot analysis in HepG2 cell line lysates (35ug/lane).This demonstrates the STOML2 antibody detected the STOML2 protein (arrow).)
STOML2 is similar in sequence to stomatin. It is a 356 amino acid protein with a calculated molecular mass of 38.5 kDa. STOML2 has 3 potential initiator sites, all sharing the same open reading frame. The STOML2 protein contains the cognate stomatin family consensus sequence, but it lacks the characteristic N-terminal hydrophobic domain and palmitoylation consensus sequence. STOML2 shares greatest sequence homology with stomatin and SLP1 in a region predicted to contain beta sheet and alpha helix structures. Northern blot analysis detected a 1.5 kb STOML2 transcript in all tissues examined, with highest levels in heart, liver, and pancreas. Western blot analysis detected STOML2 at apparent molecular masses of 45.5 kDa or 44.6 kDa in all human and mammalian cell lines and tissues examined, including red blood cells. Some cells also showed a faint band at about 34.3 kDa, which may represent translation from an alternate initiation site.
Antigen Type: Synthetic Peptide. Antigen Source: HUMAN. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing STOML2 are readily searchable from our website. Different antibodies against the same target such as STOML2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Cell Transformation, Neoplastic, Death, Kidney Diseases, Neoplasm Metastasis, Neoplasms, Experimental, Precancerous Conditions, Thyroid Diseases are some of the diseases may be linked to STOML2 Antibody (Center).